Mode
Text Size
Log in / Sign up
N/A N=12 Treatment

Restoring Walking With a Powered Exoskeleton After Spinal Cord Injury

Spinal Cord Injury

Enrolled (actual)
12
Serious AEs
0.0%
Results posted
Oct 2021
Primary outcome: Primary: Physiological Cost Index (PCI) Ratio — 3.34 unit less

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
ReWalk (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Alberta
Primary completion
Aug 2018

Outcome Measures

OutcomeResultp-value
PRIMARY
Physiological Cost Index (PCI) Ratio
3.34
SECONDARY
10 Meter Walk Test
0.41; 0.42
SECONDARY
Max Distance
1309
SECONDARY
Limits of Stability - Sitting
1.6; 4.5
SECONDARY
Sitting Sway
-1.59; -1.38
SECONDARY
McGill Pain Questionnaire
14.4; 16.2; 11.1
SECONDARY
Spinal Cord Assessment Tool for Spastic Reflexes (SCATS)
5.91; 5.57; 6.25
SECONDARY
Motor Evoked Potentials
402; 353
SECONDARY
Change From Baseline in Manual Muscle Test at End of Training
0.4

Summary

Powered exoskeletons have emerged recently, promising to offer walking to individuals with severe spinal cord injury who are unable to walk. We will use the ReWalk exoskeleton to train walking in individuals with chronic, severe spinal cord injury (SCI). We will determine the characteristics of individuals who most benefit from such training, and identify the neuroplasticity induced by the training. We will further determine the feasibility of the ReWalk for home and community ambulation.

Eligibility Criteria

Inclusion Criteria

  • non-progressive spinal cord injury ≥1 year post-injury
  • Body height between 5'3" and 6'4"
  • Body weight ≤82 kg
  • Uses wheelchair as primary mode of mobility
  • If able to walk, walks at ≤0.4 m/s
  • Arm strength sufficient to control forearm crutches
  • Agree to attend intensive training of 1.5 hr/day, 4 days/wk for 14 weeks, plus testing pre and post training of approximately 2 weeks each

Exclusion Criteria

  • Contractures at the hip, knee or ankle that interferes with fitting into the ReWalk
  • Fractures within the last 2 years
  • Osteoporosis in the legs (t-score ≤-3.0)
  • Severe postural hypotension
  • Severe spasticity that interferes with use of the ReWalk
  • Active pressure sores
  • Pregnancy
  • Severe head injury
  • Conditions that preclude intensive exercise (such as high blood pressure)
  • Presence of conditions contraindicated for transcranial magnetic stimulation
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02322125). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search